More on Abbott (ABT) Q2: net profit -11.2% to $1.725B due to various charges. Gross margin +310...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

More on Abbott (ABT) Q2: net profit -11.2% to $1.725B due to various charges. Gross margin +310 bps to 63.3%, driven "by improved efficiencies across a number of operating divisions, favorable product mix and the effect of foreign exchange." Confirms 2012 guidance of $5.00-$5.10 vs. consensus of $5.04. Shares +0.35%. (PR)